WHO cautions against indiscriminate use of antibiotics

Image
Press Trust of India Kolkata
Last Updated : Oct 04 2015 | 8:57 AM IST
The World Health Organisation (WHO) has cautioned that the current practice of indiscriminate use of antibiotics is increasingly leading to resistance to medicines, persistence of infections and treatment failure.
"Immediate action is needed to stop the world from heading towards a pre-antibiotic era in which all achievements made in prevention and control of communicable diseases will be reversed," Regional Director of WHO South-East Asia Region, Dr Poonam Khetrapal Singh, said at a recent regional meeting of WHO at Dili, the capital of Timor-Leste.
Health ministers and senior health officials of 11 member countries of WHO South-East Asia Region attended the 68th meeting of the Regional Committee.
Singh urged WHO's member countries in the south-east Asia region to urgently address this threat to public health.
"Common infections and minor injuries which have been treatable for decades may once again kill millions. Resistance to antibiotics will make complex surgeries and management of several chronic illnesses like cancer extremely difficult," she said.
Without effective antimicrobial medicines, a number of common infections such as hospital-acquired ventilator associated pneumonias, urinary tract infections, diarrhoea, gonorrhoea, tuberculosis and malaria are already becoming harder to treat, the WHO official said.
"And the problem is compounding. Unless we act now, the consequences might be irreversible," the regional director warned.
A recent forecast for the potential human and economic cost estimates 10 million deaths per year globally and two to 3.5 per cent less global gross domestic product by 2050 if antimicrobial resistance goes unchecked, she said.
Reduced productivity from persisting illness, and its cost of treatment, adds to the economic loss, Singh said, adding that "comprehensive and integrated national action plans are needed to respond to antimicrobial resistance".
Countries need to strengthen the monitoring of the extent and cause of antibiotic resistance, improve infection-control in hospitals and regulate and promote appropriate use of medicines besides creating increased awareness among the general public as well as health workers and pharmacists, she said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 04 2015 | 8:57 AM IST

Next Story